
Growth of the zzso portfolio remains of strategic importance to zzso and the adoption of new technologies to allow us to enhance this portfolio is central to this zzso With the move away from classical hormonal and zzso therapies to the development of more targeted approaches for the treatment of cancer, an understanding of the molecular pathology of the disease state is becoming zzso Our understanding of the zzso of cancer has increased dramatically over the last few decades and with the publication of the human zzso and the zzso explosion in the field of zzso and zzso zzso is turning its attention to using these new technologies to enhance the zzso R&D zzso In particular, the fields of zzso and zzso in relation to zzso have received much attention and this has been mirrored zzso both within the zzso and academic zzso Future products from the zzso zzso portfolio will increasingly rely on the use of zzso and zzso for patient identification and stratification, whilst these technologies will also provide a source of novel zzso and zzso that may allow us to streamline the R&D process and help us to better understand the biological basis of the diseases we are aiming to zzso The zzso perspective is, however, pragmatic enough to appreciate the practical challenges involved in applying zzso and zzso not only for early drug development, but also in the organization of the zzso infrastructure to undertake timely and complex laboratory zzso Finally, validation of this approach will require carefully controlled clinical zzso 

